Nilotinib Benefits Relapsed Patients With CML After Treatment Discontinuation Targeted Oncology 2:03 5 years ago 1 899 Скачать Далее
Imugene reports promising results in Phase 1b trial for azer-cel in DLBCL Imugene Limited 4:54 9 hours ago 219 Скачать Далее
Imugene reports promising results in Phase 1b trial for azer-cel in DLBCL Proactive Investors 4:54 9 hours ago 227 Скачать Далее
RECOURSE Trial: Phase III trial: The Onset of Neutropenia as a Treatment Response Indicator Oncology.TV 3:51 7 years ago 67 Скачать Далее
Considering a Myelofibrosis Clinical Trial? Questions You Should Ask Patient Empowerment Network 5:02 5 months ago 15 Скачать Далее
Dr. Cortes on the 192-Week Follow-Up Results of the ENESTop Trial in CML OncLive 2:00 5 years ago 95 Скачать Далее
Overview of the CLLR3 trial of obinutuzumab VJHemOnc – Video Journal of Hematology & HemOnc 1:39 7 years ago 93 Скачать Далее
Update on ENESTop: TFR in CML after discontinuing nilotinib VJHemOnc – Video Journal of Hematology & HemOnc 2:36 5 years ago 263 Скачать Далее
Neutrodiet trial: comparing infections using NRD and PD in patients with neutropenia after HSCT VJHemOnc – Video Journal of Hematology & HemOnc 4:18 1 year ago 89 Скачать Далее
7-year follow-up of RESONATE-2 trial for CLL/SLL VJHemOnc – Video Journal of Hematology & HemOnc 2:05 3 years ago 235 Скачать Далее
